Northwest Arkansas Democrat Gazette

HIV injection access poised to expand

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year. The ...
Yahoo

U.S. FDA approves GSK unit's long-acting HIV injection

(Reuters) - The U.S. Food and Drug Administration on Thursday approved a long-acting HIV injection from British drugmaker GlaxoSmithKline's HIV treatment division, ViiV Healthcare. "This is the first ...
Yahoo

GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill

LONDON (Reuters) - British drugmaker GSK's HIV treatment division, ViiV Healthcare, published data on Wednesday showing its long-acting HIV injection is as effective as the market-leading daily pill ...
Newspoint on MSN

Get one injection in a year and get rid of the tension of HIV! It can be a boon for such people

HIV New Injection Trial: Scientists have got success with a new injection of HIV. Taking this injection once a year can ...
CNBC

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...
WGHP

FDA approves first HIV prevention injection

(The Hill) – The Food and Drug Administration (FDA) has approved the first injectable treatment for HIV pre-exposure prophylaxis, providing another option to help individuals at-risk avoid sexually ...
The Inlander

FDA approves twice-yearly injection that prevents HIV, thanks in part to research by a Spokane doctor

A few weeks ago, Grant Ogren and Rhea Ashby-Durall, the executive director and the outreach manager of SAN (formerly Spokane AIDS Network), met with their representative from Gilead Sciences, the ...